LSA
PTCT icon

Leonteq Securities AG’s PTC Therapeutics PTCT Stock Holding History

Leonteq Securities AG’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-100
Closed -$6.81K – 1361
2026
Q1 		$6.81K Hold
100
– – ﹤0.01% 1093
2025
Q4 		$7.6K Buy
+100
New +$7.27K ﹤0.01% 1219
2025
Q1 		– Sell
-88
Closed -$3.97K – 1323
2024
Q4 		$3.97K Sell
88
-29
-25% -$1.24K ﹤0.01% 1117
2024
Q3 		$4.34K Hold
117
– – ﹤0.01% 1053
2024
Q2 		$3.58K Sell
117
-1,350
-92% -$43.7K ﹤0.01% 1073
2024
Q1 		$42.7K Sell
1,467
-1,167
-44% -$32.7K ﹤0.01% 800
2023
Q4 		$72.6K Sell
2,634
-848
-24% -$19.4K ﹤0.01% 701
2023
Q3 		$78K Buy
3,482
+2,731
+364% +$102K ﹤0.01% 704
2023
Q2 		$30.5K Buy
+751
New +$36.7K ﹤0.01% 908
2021
Q3 		– Sell
-638
Closed -$27K – 1203
2021
Q2 		$27K Buy
638
+127
+25% +$5.44K ﹤0.01% 913
2021
Q1 		$24.2K Buy
+511
New +$30.3K ﹤0.01% 867

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Leonteq Securities AG's PTCT Position: Q2 2026 in Review

Leonteq Securities AG sold out of PTC Therapeutics (PTCT) in Q2 2026, closing a stake of 100 shares — an estimated $6.81K sold.

Leonteq Securities AG first reported a position in PTCT in Q1 2021 and held it in 11 quarters. The position peaked at $78K in Q3 2023. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Leonteq Securities AG reported no remaining PTC Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Leonteq Securities AG sold 100 PTC Therapeutics shares in Q2 2026, an estimated $6.81K.
  • Leonteq Securities AG first reported a position in PTC Therapeutics in Q1 2021 and held it in 11 quarters.
  • Leonteq Securities AG's PTC Therapeutics position peaked at $78K in Q3 2023.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.